Abeona Therapeutics
ABEO
37 hedge funds and large institutions have $15.8M invested in Abeona Therapeutics in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 16 reducing their positions, and 17 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less funds holding
Funds holding: 45 → 37 (-8)
19% less capital invested
Capital invested by funds: $19.4M → $15.8M (-$3.6M)
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
75% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Nexthera Capital
New York
|
+$273K |
| 2 |
Millennium Management
New York
|
+$161K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$115K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$41K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$39.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$902K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$726K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$244K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$192K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$175K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
BlackRock
New York
| – | -$1K | -14 | Closed |
|
|
CG
52
Cutler Group
San Francisco,
California
| – | -$547 | -8 | -40% |
|
53
Simplex Trading
Chicago,
Illinois
| – | -$547 | -8 | Closed |
|
54
Barclays
London,
United Kingdom
| – | +$547 | +8 | New |
|
ABEO Hedge Fund Activity: Q2 2016 in Review
37 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q2 2016, worth a combined $15.8M — down 19% from $19.4M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ABEO and 9 opened new positions — a net loss of 8 holders — while 16 trimmed existing stakes and 4 added.
The largest buyer was Nexthera Capital, opening a new position worth an estimated $273K. The largest seller was Sphera Funds Management, cutting an estimated $902K.
- 37 institutional investors held Abeona Therapeutics (ABEO) as of Q2 2016, down from 45 in Q1 2016.
- Funds reported $15.8M of Abeona Therapeutics stock for Q2 2016, down 19% quarter-over-quarter.
- 9 funds opened new Abeona Therapeutics positions in Q2 2016 and 17 closed out, a net change of -8 holders.
- The largest Abeona Therapeutics buyer in Q2 2016 was Nexthera Capital, an estimated $273K added.
- The largest Abeona Therapeutics seller in Q2 2016 was Sphera Funds Management, an estimated $902K sold.
Based on aggregated 13F filings for Q2 2016.